The concept of innovative drugs has strengthened again, with Staidson BioPharm rising over 15%, reaching a three-year high
In the morning session, Staidson BioPharm rose over 15%, reaching a new three-year high, while JENKEM, BrightGene, NKF, Sunshine Guojian Pharmaceutical, and InventisBio also saw significant gains